Insider Trading Summary for Collegium Pharmaceutical, Inc (COLL): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
23-May-22 4:55 PM View:	19-May-22 Grant 0	Santini Gino Director		Collegium Pharmaceutical, Inc - COLL	32% 44.14K to 58.17K	0	0	--	--	Show Txns Hide Txns

23-May-22 4:43 PM View:	19-May-22 Grant 0	Bohlin Garen G Director		Collegium Pharmaceutical, Inc - COLL	67% 20.95K to 34.98K	0	0	--	--	Show Txns Hide Txns

23-May-22 4:43 PM View:	19-May-22 Grant 0	Fallon John A. Director		Collegium Pharmaceutical, Inc - COLL	60% 23.32K to 37.36K	0	0	--	--	Show Txns Hide Txns

23-May-22 5:42 PM View:	19-May-22 Grant 0	Melincoff Gwen A Director		Collegium Pharmaceutical, Inc - COLL	67% 20.95K to 34.98K	0	0	--	--	Show Txns Hide Txns

14-Feb-23 5:18 PM View:	13-Feb-23 Sale (Planned) ($586.28K)	Kuhlmann Shirley R. EVP and General Counsel		Collegium Pharmaceutical, Inc - COLL	(7%) 148.38K to 137.5K	0	($703.31K) (26%)	--	$18.07 - $20.01	Show Txns Hide Txns

23-May-22 4:44 PM View:	19-May-22 Grant 0	Freund John Gordon Director		Collegium Pharmaceutical, Inc - COLL	22% 64.36K to 78.4K	0	0	--	--	Show Txns Hide Txns

14-Feb-23 5:16 PM View:	13-Feb-23 Planned Option Sale ($302.40K)	Ciaffoni Joseph President and CEO Director		Collegium Pharmaceutical, Inc - COLL	23% 324.85K to 400.09K	0	0	--	--	Show Txns Hide Txns

03-Mar-23 4:08 PM View:	01-Mar-23 Private Sale (Planned) ($355.75K)	Dreyer Scott EVP & Chief Commercial Officer		Collegium Pharmaceutical, Inc - COLL	11% 121.23K to 134.88K	0	0	--	--	Show Txns Hide Txns

27-Dec-22 7:17 PM View:	27-Dec-22 Planned Option Sale ($470.25K)	Heffernan Michael Thomas Director		Collegium Pharmaceutical, Inc - COLL	100% 13.99K to 28.02K	0	0	--	--	Show Txns Hide Txns

23-May-22 4:43 PM View:	19-May-22 Grant 0	Balice-Gordon Rita J. Director		Collegium Pharmaceutical, Inc - COLL	94% 14.97K to 29.0K	0	0	--	--	Show Txns Hide Txns

17-Mar-23 4:11 PM View:	15-Mar-23 Private Sale (Planned) ($752.16K)	Tupper Colleen EVP & Chief Financial Officer		Collegium Pharmaceutical, Inc - COLL	11% 94.65K to 105.42K	0	($75.47K) (5%)	--	$17.35	Show Txns Hide Txns

23-May-22 4:44 PM View:	19-May-22 Grant 0	McFarlane Neil F. Director		Collegium Pharmaceutical, Inc - COLL	100% 0 to 31.88K	0	0	--	--	Show Txns Hide Txns

14-Feb-23 5:19 PM View:	10-Feb-23 Grant 0	Smith Thomas B EVP and Chief Medical Officer		Collegium Pharmaceutical, Inc - COLL	100% 0 to 31.18K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	($778.78K)	$17.35 - $20.01

Collegium Pharmaceutical, Inc (COLL)

Last Year

31-Mar-22 -- 30-Mar-23

Company Sentiment

Drugs - Generic

Drugs

Two Year Chart

31-Mar-21 -- 30-Mar-23

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades